Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating promt1-mmp

Cancer Investigation

Volumn 30, Issue 8, 2012, Pages 583-592

  Vilen, Suvi Tuuli ^a,c   Suojanen, Juho ^a   Salas, Fidel ^b   Risteli, Juha ^b   Ylipalosaari, Merja ^b   Itkonen, Outi ^a,c   Koistinen, Hannu ^c   Baumann, Marc ^d   Stenman, Ulf Håkan ^a,c   Sorsa, Timo ^a   Salo, Tuula ^b,e   Nyberg, Pia ^b,e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Claudin 7; MT1 MMP; Oral tongue squamous cell carcinoma; Trypsin 2

Indexed keywords

ACYL COENZYME A DESATURASE; CADHERIN; CALGRANULIN A; CHOLINESTERASE; CLAUDIN 7; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE 3; COMPLEMENT FACTOR H; FIBRONECTIN; GANGLIOSIDE GALACTOSYLTRANSFERASE; INTERFERON INDUCED PROTEIN 44 LIKE; INTERLEUKIN 1 RECEPTOR TYPE II; KELCH LIKE ECH ASSOCIATED PROTEIN 1; KERATIN; MATRIX METALLOPROTEINASE 14; OVALBUMIN; PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA2; TRYPSIN; TRYPSIN 2; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; CELL MIGRATION; CHROMOSOME 20; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID HYPERPLASIA; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SINUS HISTIOCYTOSIS; TIGHT JUNCTION; TONGUE CARCINOMA; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CLAUDINS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MATRIX METALLOPROTEINASE 14; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PROTEIN PRECURSORS; TIGHT JUNCTIONS; TONGUE NEOPLASMS; TRYPSIN; TRYPSINOGEN; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866881454     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.716467     Document Type: Article

References (54)

1. Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, Hayashi R, Ebihara S, Cho SJ, Ochiai A. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 2004;10:166-172.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;5:646-674.
3. Koivunen E, Itkonen O, HalilaH, Stenman UH. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2. Cancer Res 1990;8:2375-2378.
4. Ichikawa Y, Koshikawa N, Hasegawa ST, Ishikawa T, Momiyama N, Kunizaki C, Takahashi M, Moriwaki Y, Akiyama H, Yamaoka H, Yanoma S, Tsuburaya A, Nagashima Y, Shimada H, Miyazaki K. Marked increase of trypsin(ogen) in serum of linitis plastica (gastric cancer, borrmann 4) patients. Clin Cancer Res 2000;4:1385-1388.
5. Nyberg P, Moilanen M, Paju A, Sarin A, Stenman UH, Sorsa T, Salo T. MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J Dent Res 2002;12:831-835.
6. Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum. Clin Cancer Res 2004;14:4761-4768.
7. Nyberg P, Ylipalosaari M, Sorsa T, Salo T. Trypsins and their role in carcinoma growth. Exp Cell Res 2006;8:1219-1228.
8. Vilen ST, Nyberg P, Hukkanen M, Sutinen M, Ylipalosaari M, Bjartell A, Paju A, Haaparanta V, Stenman UH, Sorsa T, Salo T. Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma. Exp Cell Res 2008; 4:914-926.
9. Koshikawa N, Yasumitsu H, Umeda M, Miyazaki K. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 1992;18:5046-5053.
10. MoilanenM, Sorsa T, StenmanM, Nyberg P, Lindy O, Vesterinen J, Paju A, Konttinen YT, Stenman UH, Salo T. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Biochemistry 2003;18:5414-5420.
11. Sorsa T, Salo T, Koivunen E, Tyynela J, Konttinen YT, Bergmann U, Tuuttila A, Niemi E, Teronen O, Heikkilä P, Tschesche H, Leinonen J, Osman S, Stenman UH. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 1997;34:21067-21074.
12. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metast Rev 2006;1:9-34.
13. Myoung H, Kim MJ, Hong SD, Lee JI, Lim CY, Hong SP. Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma. Cancer Lett 2002;2:201-209.
14. Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park CS, Sei M. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997;1:139-144.
15. Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006;1:1-8.
16. Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M. Processing of a precursor of 72-kilodalton type IV collagenase/ gelatinaseAby a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 1996;11:2535-2538.
17. Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 2009;4:872-891.
18. Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol 2010;3:142-149.
19. Gonzalez-Mariscal L, Lechuga S, Garay E. Role of tight junctions in cell proliferation and cancer. Prog Histochem Cytoc 2007;1:1-57.
20. Oliveira SS, Morgado-Diaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci 2007;1:17-28.
21. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005;21:9603-9606.
22. Lourenco SV, Coutinho-Camillo CM, Buim ME, Carvalho AC, Lesse RC, Pereira CM, Vettore AL, Carvalho AL, Freanani JH, Kowalski LP, Soares FA. Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma. Histopathology 2010;5:689-698.
23. Bello IO, Vilen ST, Niinimaa A, Kantola S, Soini Y, Salo T. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol 2008;8:1212-1220.
24. HeikkiläP, Suojanen J, PiriläE, Väänänen A, Koivunen E, Sorsa T, Salo T. Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides. Int J Cancer 2006;9:2202-2209.
25. Laaksonen M, Suojanen J, Nurmenniemi S, Läärä E, Sorsa T, Salo T. The enamel matrix derivative (emdogain) enhances human tongue carcinoma cells gelatinase production, migration and metastasis formation. Oral Oncol 2008;8:733-742.
26. Suojanen J, Salo T, Koivunen E, Sorsa T, Pirilä E. A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth. Cancer Biol Ther 2009;24:2362-2370.
27. Itkonen O, Koivunen E, Hurme M, Alfthan H, Schröder T, Stenman UH. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;6:712-718.
28. Salo S, HaakanaH, Kontusaari S, Hujanen E, Kallunki T, Tryggvason K. Laminin-5 promotes adhesion and migration of epithelial cells: identification of a migration-related element in the gamma2 chain gene (LAMC2) with activity in transgenic mice.Matrix Biol 1999;18:197-210.
29. Nurmenniemi S, Sinikumpu T, Alahuhta I, Salo S, Sutinen M, Santala M, Risteli J, Nyberg P, Salo T. A novel organotypic model mimics the tumor microenvironment. Am J Pathol 2009;3:1281-1291.
30. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;4:635-640.
31. Koistinen H, Koistinen R, Zhang WM, Valmu L, Stenman UH. Nexin-1 inhibits the activity of human brain trypsin. Neuroscience 2009;1:97-102.
32. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;5930:1029-1033.
33. Singh AB, Sharma A, Dhawan P. Claudin family of proteins and cancer: an overview. J Oncol 2010;2010:541957.
34. Lioni M, Brafford P, Andl C, Rustgi A, El-Deiry W, Herlyn M, Smalley KS.Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007;2:709-721.
35. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;17:2634-2640.
36. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation regulation by TIMP-2 and TIMP-3. J Biol Chem 1996;29:17119-17123.
37. Koivunen E, Saksela O, Itkonen O, Osman S, Huhtala ML, Stenman UH. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer 1991;4:592-596.
38. Schuh JC. Trials, tribulations, and trends in tumor modeling in mice. Toxicol Pathol 2004;1:53-66.
39. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;6:1420-1428.
40. Cardiff RD. The pathology of EMT in mouse mammary tumorigenesis. J Mammary Gland Biol Neoplasia 2010;2:225-233.
41. Peng CW, Liu XL, Chen C, Liu X, Yang XQ, Pang DW, Zhu ZB, Li Y. Pattern of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment. Biomaterials 2011;32:2907-2917.
42. Kademani D. Oral cancer. Mayo Clin Proc 2007;82:878-887.
43. Fritz V, Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 2010;31:4369-4377.
44. Bause E, Bieberich E, Rolfs A, Völker C, Schmidt B. Molecular cloning and primary structure of Man9-mannosidase from human kidney. Eur J Biochem 1993;2:535-540.
45. Sprong H, Kruithof B, Leijendekker R, Slot JW, van Meer G, van der Sluijs P. UDP-galactose: Ceramide galactosyltransferase is a class I integral membrane protein of the endoplasmic reticulum. J Biol Chem 1998;40:25880-25888.
46. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010;9:1509-1515.
47. Michaud-Levesque J, Richard S. Thrombospondin-1 is a transcriptional repression target of PRMT6. J Biol Chem 2009;32:21338-21346.
48. Kummer JA, Micheau O, Schneider P, Bovenschen N, Broekhuizen R, Quadir R, Strik MC, Hack CE, Tschopp J. Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis. Cell Death Diff 2007;8:1486-1496.
49. Matter K, Aijaz S, Tsapara A, Balda MS. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005;5:453-458.
50. Dhawan P, Singh AB, DeaneNG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD. Claudin-1 regulates cellular transformation andmetastatic behavior in colon cancer. J Clin Invest 2005;7:1765-1776.
51. Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, Sato H. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem 2001;30:28204-28211.
52. Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 2006;10:5251-5257.
53. Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, Quaranta V. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 2003;1:197-209.
54. Polette M, Birembaut P. Membrane-type metalloproteinases in tumor invasion. Int J Biochem Cell Biol 1998;11:1195-1202.